Materials and Methods
Cancer
MAY, CANCER
This open-label single institutional Phase I/Ib trial was conducted between May 2019 and June 2022 with institutional review board (IRB 18496) approval at the City of Hope National Cancer Center. The trial was conducted in accordance with the World Medical Association Declaration of Helsinki, International Conference on Harmonization Good Clinical Practice guidelines, and the US code of federal regulations. Informed consent forms were signed by all patients prior to study entry. This study is registered at the ClinicalTrials.gov under number NCT03853707.